These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 38074028)
1. Exploring the Prognostic Significance and Immunotherapeutic Potential of Single-Cell Sequencing-Identified Long Noncoding RNA (LncRNA) in Patients With Non-small Cell Lung Cancer. Chen L; Wang L; Xiong Z; Zhu X; Chen L Cureus; 2023 Nov; 15(11):e48436. PubMed ID: 38074028 [TBL] [Abstract][Full Text] [Related]
2. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma. Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X Front Genet; 2022; 13():975905. PubMed ID: 36313456 [No Abstract] [Full Text] [Related]
3. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma. Huang Y; Gong P; Su L; Zhang M Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P Front Oncol; 2023; 13():972558. PubMed ID: 37064115 [TBL] [Abstract][Full Text] [Related]
5. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Xu Q; Xu H; Chen S; Huang W Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040 [No Abstract] [Full Text] [Related]
6. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma. Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203 [TBL] [Abstract][Full Text] [Related]
7. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma. Pang Y; Wang Y; Zhou X; Ni Z; Chen W; Liu Y; Du W Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674979 [TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma. Zhang H; Cao C; Xiong H Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma. Chen JH; Wu X; Wang ZM; Liu ZY; He BX; Song WP; Zhang WZ J Thorac Dis; 2023 Mar; 15(3):1373-1386. PubMed ID: 37065578 [TBL] [Abstract][Full Text] [Related]
10. Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma. Wang F; Lin H; Su Q; Li C World J Surg Oncol; 2022 Sep; 20(1):275. PubMed ID: 36050740 [TBL] [Abstract][Full Text] [Related]
11. Prognostic analysis of Li D; Fan X; Zuo L; Wu X; Wu Y; Zhang Y; Zou F; Sun Z; Zhang W Ann Transl Med; 2022 Dec; 10(24):1356. PubMed ID: 36660710 [TBL] [Abstract][Full Text] [Related]
12. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y Front Oncol; 2022; 12():876660. PubMed ID: 35747790 [TBL] [Abstract][Full Text] [Related]
13. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer. Pan Y; Zhang Q; Zhang H; Kong F Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225 [TBL] [Abstract][Full Text] [Related]
14. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
15. A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma. Yu S; Tang L; Zhang Q; Li W; Yao S; Cai Y; Cheng H Hereditas; 2023 Jul; 160(1):31. PubMed ID: 37482612 [TBL] [Abstract][Full Text] [Related]
16. A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma. Wang X; Jing H; Li H Transl Lung Cancer Res; 2023 Feb; 12(2):230-246. PubMed ID: 36895935 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis. Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ Front Oncol; 2022; 12():1022097. PubMed ID: 36300102 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M Front Immunol; 2022; 13():891175. PubMed ID: 35990668 [TBL] [Abstract][Full Text] [Related]
19. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma. Tan Y; Lu L; Liang X; Chen Y World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978 [TBL] [Abstract][Full Text] [Related]
20. ER stress-related mRNA-lncRNA co-expression gene signature predicts the prognosis and immune implications of esophageal cancer. Li F; Ma J; Yan C; Qi Y Am J Transl Res; 2022; 14(11):8064-8084. PubMed ID: 36505280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]